<SEC-DOCUMENT>0001437749-21-024344.txt : 20211027
<SEC-HEADER>0001437749-21-024344.hdr.sgml : 20211027
<ACCEPTANCE-DATETIME>20211027110936
ACCESSION NUMBER:		0001437749-21-024344
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211025
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211027
DATE AS OF CHANGE:		20211027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		211351353

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets20211026b_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:pets="http://www.pets.com/20211025"><head>
	<title>pets20211026b_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 10/27/2021 1:51:01 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20218K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20218K" name="dei:EntityCentralIndexKey">0001040130</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="pets-20211025.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20218K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-10-25</xbrli:startDate>
<xbrli:endDate>2021-10-25</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b><br />
<b>SECURITIES AND EXCHANGE COMMISSION</b><br />
<b>Washington, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20218K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b><br />
<b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="d20218K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 25, 2021</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td colspan="5" style="vertical-align:top;width:3.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityRegistrantName"><b><span style="text-decoration: underline;">PetMed Express, Inc.</span></b></ix:nonNumeric><br />
			&#xa0;(Exact name of registrant as specified in its charter)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b><span style="text-decoration: underline;">Florida</span></b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:20%;">&#xa0;</td>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityFileNumber"><b><span style="text-decoration: underline;">000-28827</span></b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:20%;">&#xa0;</td>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityTaxIdentificationNumber"><b><span style="text-decoration: underline;">65-0680967</span></b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction<br />
			of incorporation)</div>
			</td>
			<td style="vertical-align:top;width:20%;">&#xa0;</td>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission<br />
			File Number)</div>
			</td>
			<td style="vertical-align:top;width:20%;">&#xa0;</td>
			<td style="vertical-align:top;width:20%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer<br />
			Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt;">&#xa0;</div>

<div style="margin: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressAddressLine1"><b><span style="text-decoration: underline;">420 South Congress Avenue</span></b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressCityOrTown"><b><span style="text-decoration: underline;">Delray Beach</span></b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressStateOrProvince"><b><span style="text-decoration: underline;"><b><span style="text-decoration: underline;">FL</span></b></span></b></ix:nonNumeric> <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressPostalZipCode"><b><span style="text-decoration: underline;">33445</span></b></ix:nonNumeric></span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices) (Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt;">&#xa0;</div>

<div style="margin: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:97.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">(<ix:nonNumeric contextRef="d20218K" name="dei:CityAreaCode"><b><span style="text-decoration: underline;">561</span></b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20218K" name="dei:LocalPhoneNumber"><b><span style="text-decoration: underline;">526-4444</span></b></ix:nonNumeric></span></b></div>
			</td>
			<td style="vertical-align:top;width:2.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:97.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>
			</td>
			<td style="vertical-align:top;width:2.2%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="margin: 0pt;">&#xa0;</div>

<div style="margin: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Not Applicable</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 95%; margin-left: 18pt; margin-right: auto;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-color: rgb(0, 0, 0); border-style: solid; border-width: thin thin 1px; vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Title of each class</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-top: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Trading Symbol(s)</div>
			</td>
			<td style="border-color: rgb(0, 0, 0); border-style: solid; border-width: thin thin 1px; vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; border-left: thin solid rgb(0, 0, 0); border-right: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:TradingSymbol">PETS</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 34%; border-right: thin solid rgb(0, 0, 0); border-left: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Global Select Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 45pt 0pt 18pt; text-align: left; text-indent: 0pt; background-color: rgba(0, 0, 0, 0); color: rgb(0, 0, 0);">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 45pt 0pt 18pt; text-align: left; text-indent: 0pt;">Emerging growth company <ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 45pt 0pt 18pt; text-align: left; text-indent: 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 2.02</b>&#xa0;&#xa0;&#xa0;<b>Results of Operations and Financial Condition.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">On Octpber 25, 2021, PetMed Express, Inc. (the &#8220;Company&#8221;) discussed its financial results for the quarter ended on September 30, 2021. A copy of this conference call transcript is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01</b>&#xa0;&#xa0;&#xa0;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(d)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Exhibits.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">99.1 &#8211;&#xa0;PetMed Express, Inc. conference call transcript dated October 25, 2021.</div>
			</td>
		</tr>
		<tr>
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">104 &#8211;&#xa0;Cover Page Interactive Data File (formatted as Inline XBRL).</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXHIBIT INDEX</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt; font-family: Times New Roman; font-size: 10pt;"><span style="text-decoration: underline;">Exhibit No.</span></td>
			<td style="width: 18pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#xa0;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Description</span></div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 54pt; font-family: Times New Roman; font-size: 10pt;">99.1</td>
			<td style="width: 18pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#xa0;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><a href="ex_297703.htm" style="-sec-extract:exhibit;">PetMed Express, Inc. conference call transcript dated October 25, 2021.</a></div>
			</td>
		</tr>
		<tr>
			<td style="width: 54pt; font-family: Times New Roman; font-size: 10pt;">104</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">Cover Page Interactive Data File (formatted as Inline XBRL).</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: October 27, 2021</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PETMED EXPRESS, INC.</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 45%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="vertical-align: top; width: 45%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">/s/ Bruce S. Rosenbloom</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:</div>
			</td>
			<td style="vertical-align: top; width: 45%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bruce S. Rosenbloom</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:</div>
			</td>
			<td style="vertical-align: top; width: 45%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center;">2</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_297703.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_297703.htm</title>

	<!-- Generated by ThunderDome Portal - 10/27/2021 1:44:45 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 99.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PETMED EXPRESS, INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>QUARTER ENDED SEPTEMBER 30, 2021</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONFERENCE CALL TRANSCRIPT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OCTOBER 25, 2021 AT 4:30 P.M. ET</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Welcome to the PetMeds Conference Call to Review the Financial Results for the Second Fiscal Quarter ended on September 30, 2021. At the request of the Company, this conference call is being recorded. Founded in 1996, PetMeds is America&#8217;s Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications, and other health products for dogs, cats and horses direct to the customer. PetMeds markets its products through national advertising campaigns, which direct customers to order by phone or on the internet, to increase the recognition of the PetMeds brand name. PetMeds provides an attractive alternative for obtaining pet medications in terms of convenience, price, and ease of ordering and rapid home delivery. At this time, I would like to turn the call over to the Company&#8217;s Chief Financial Officer, Mr. Bruce Rosenbloom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Bruce Rosenbloom</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I would like to welcome everybody here today. I would like to remind everyone that the first portion of this conference call will be listen-only, until the question-and-answer session, which will be later in the call. Also, certain information that will be included in this press conference may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission. Let me now introduce our newly appointed CEO and President, Matt Hulett. Matt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thanks, Bruce.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Good morning, and thank you for joining us. My name is Matt Hulett and I&#8217;m the new CEO of PetMed. I&#8217;m incredibly honored and enthusiastic to join this iconic company and I am excited to be on this earnings call today. I would like to begin by thanking Bruce Rosenbloom for acting as interim Chief Executive Officer prior to my arrival. Before we update you on our progress on Q2. I would like to first share my personal thoughts and motivations regarding why I am so optimistic about Petmeds and our future.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">First, I would like to introduce you to my dog Harry who is featured on this slide. He&#8217;s the latest addition to our family and he&#8217;s also a puppy. In fact, Harry is the first dog for my family. Our family had no idea what we were getting ourselves into. It's like having a newborn again and as many of you fellow pet parents know, puppies can be challenging. We also can&#8217;t imagine not having Harry in our lives and we think of him as a member of our family. Personally, it is fulfilling to be involved in an organization where you can spend your time and energy on a business that has such positive social impacts on society while you are focused on generating returns for shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Now that we&#8217;ve established my personal connection to the business, I&#8217;d like to spend some time walking through the rationale as to why I believe Petmeds is a great long-term investment. Having a large addressable market is important. It enables more optionality for new brands and products to be developed. It provides more opportunity to develop a myriad of go-to-market strategies targeted at different cohorts of customer segments. This also means that there&#8217;s room for more market participants, and for those market participants to coexist and flourish.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The pet industry&#8217;s total addressable market is very large, and it is growing. Currently, it is over $100 billion and the service addressable pet medication market where we participated to date is approximately $10 billion. We are one of the leading pet pharmacies today and as such I see a future where we can extend our already sizable customer reach combined with our widely respected and known brand into additional segments of the total pet care market as our future vision comes fully into focus.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 1 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to the benefits of participating in a large market, the market timing is also considerably favorable. Pet ownership has always been high in the United States, but, we have seen an increase in pet ownership especially due to the macro effects of COVID-19. Pet ownership has surged to record heights and now seven out of ten U.S. households own a pet. Those new and existing pet parents will need more pet medications and other related healthcare services for their pet family members.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As we have seen in other digital e-commerce verticals, the adoption curve of the digitization of retail is a favorable tailwind. This pull-forward of digital-based retail experiences has now given customers a taste of the future and has created new buying habits of purchasing more products and services online. Today, our addressable market is largely dominated by offline sales and we see the trend to purchase online as clearly very favorable to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pet parents see their pets as an extension of their own families and they are increasingly demanding more healthy pet care options for their furry friends. We see this as a positive trend for Petmeds and an opportunity. For example, we have increased the number of products that we carry and have started to include specialty dog food and higher-end wellness products, which we believe have contributed to the increase in our average customer order value.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Lastly, just like we&#8217;ve seen in the human health care market, COVID-19 accelerated the increasing trend to the digitization of health care. In fact, in the pet market, for the first time regulations related to in-person veterinary visits and prescription fulfillment were temporarily waived and moved online in unprecedented ways. We think this opens the door to the acceleration of digital-based telehealth services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As I look at the business, there are several key competitive advantages that we can leverage in the future. First, our brand is widely known and trusted. Having a strong brand takes years to develop and our customers look to Petmeds as their trusted pharmacy and as their pet medication experts. Second, we have strong operational and quality efficiency as a pharmacy. Our customer care integration with our pharmacy is world-class, which ensures that customers get their products delivered quickly but also accurately and our vet partners receive high quality fulfillment and service delivered through our vet platform.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our deep experience with the vet community is a latent competitive advantage. We currently have one of the largest direct-to-consumer vet networks in the online retail space. Petmeds has a large network of over 70,000 veterinarians that we have worked with over the Company&#8217;s history. Our online vet portal currently has 17,000 veterinarians and vet clinics. This is a core capability and asset because it enables us to expand our fulfillment capability as we scale our business. Our prescription medication authorization rates are the highest they have ever been, which speaks volumes to the level of veterinarian cooperation we receive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our pet pharmaceutical category expertise is something that I view as a unique strength. Being a differentiated provider allows Petmeds to focus our offering especially as the market continues to get even more competitive. Again, more to come on where we see our brand and business going in the coming months.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Petmeds has long enjoyed close bonds with many of our supplier partners. Those relationships have developed over time to become even more strategic. Today, we have direct relationships with all of our major suppliers and we partner with them to market their products to our customer base.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our customer service and overall customer centricity ethos permeates our culture and our team. I have personally sat in on hours of phone calls between our customers and our service agents and I have never experienced such a tightly integrated and empathetic customer-centric organization in my entire career. We don&#8217;t just have a transactional interaction with our customers, we have built trusted relationships.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Before we comment on our earnings performance, I would like to reiterate several compelling reasons to invest and to continue to invest in Petmeds. Petmeds has several core fundamentals that are compelling, including: a strong balance sheet. We do not have debt, we have over $100 million in cash and we are cash flow positive. We have a long history of providing shareholder returns through our dividend and a strong return on equity that has been historically over 30%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We have started to build a recurring subscription base to our customers with a program, which we just recently launched in July of this year, through our new AutoShip &amp; Save program, where we are building higher lifetime value and recurring relationships with our customers. In September, approximately 20% of our customers signed up and ordered via our AutoShip &amp; Save subscription program, and that number continues to rise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 2 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">Our customers responded very positively and enrollment in AutoShip &amp; Save has increased steadily throughout the quarter. We expect many of our reorder sales to eventually transition to AutoShip &amp; Save by the end of our fiscal year, which will only continue to strengthen our relationship with our customers. We also continue to have a large base of returning customers which is an indication of the quality of service and the value that we deliver to our customers.</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">So to sum up the core Company strengths. We have over 25 years of experience as a pure-play pet pharmacy, fully licensed in 50 States, delivering fantastic service and value which is recognized by our customers, and continues to be rewarded with their loyalty. Our NPS score is over 80, which puts us in the upper quartile, along with some of the most beloved brands in the world. We are a direct-to-consumer brand, with a rapidly growing addressable market and we have successfully serviced more than two million active customers over the last two years.</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Now, I would like to have Bruce Rosenbloom our Chief Financial Officer review our financials for the quarter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Bruce Rosenbloom</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thanks, Matt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Now, we will review the financial results. We will compare our second fiscal quarter ended on September 30, 2021, to last year&#8217;s quarter ended on September 30, 2020, and in some cases we will refer back to September 30, 2019.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Similar to the quarter ended June 30, 2021, we faced a unique situation comparing two totally different environments between 2020 pandemic and 2021 post-pandemic. We were coming off a strong September quarter last year, which was primarily driven by increased ecommerce demand as a result of the pandemic, which caused many retail stores to close and many veterinarians to be unavailable. However, during the most recent quarter, while the pandemic was abating and retail stores and veterinarians were open for business, the advertising market continued to surge with increased demand, dramatically driving up CPC and CPM rates by more than 50%. As a result, we spent approximately 33% less in advertising, due to these cost increases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the second fiscal quarter ended on September 30, 2021, sales were $67.4 million compared to sales of $75.4 million for the same period the prior year, a decrease of 10.7%, but sales were only down 3.6% versus the quarter ended September 30, 2019, prior to the pandemic. The decrease in sales was due to decreases in both new order and reorder sales. Our sales were negatively impacted by a much more competitive market, and a crowded advertising space with substantially higher costs compared to the same quarter last year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition, during the past six months there was a dramatic increase in veterinary visits by pet owners who were unable to visit their veterinarian during the pandemic. We believe the increase in veterinary visits was primarily due to pet owners needing to visit their veterinarians for their pet&#8217;s exams, and to renew their prescriptions. Since some pet owners purchase medications directly from their vets during their visit, the Company believes this negatively impacted sales, and especially reorder sales during the quarter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We were disappointed with our sales results during the quarter, however, sales were trending more positive in the months of August and September 2021 when you compare them to August and September 2019. Reorder sales decreased by 8.5% to $62.0 million for the quarter compared to reorder sales of $67.8 million for the same quarter last year, while for the quarter ended September 30, 2019, our reorder sales were $61.9 million. Encouragingly, reorder sales in the most recent quarter, while down versus a year ago, were up slightly compared to 2019, pre-pandemic. We would expect to see stronger reorder sales in the back half of Fiscal 2022, as we anticipate more prescriptions being renewed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A positive trend to highlight for the quarter was the continued increase in our average order size. Our average order value was approximately $92 for the quarter compared to $87 for the same quarter last year, and $85 for the quarter ended September 30, 2019. The increase in AOV can be attributed to a shift in our product mix to more prescription items, and less over-the-counter items, with prescription items having a higher gross margin profile in comparison to over-the-counter items.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As I mentioned earlier, during the quarter ended September 30, 2021, the advertising market was extremely competitive, and this increased demand drove up ad prices dramatically. As a result, our advertising spending was less efficient than usual and delivered fewer impressions than in prior years. Because of this, we believe our advertising spending was less effective in the most recent quarter, in its ability to attract new customers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 3 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">New order sales decreased by 30% to $5.4 million for the quarter, compared to $7.7 million for the same quarter the prior year. We acquired approximately 65,000 new customers in our second fiscal quarter, compared to 96,000 for the same period the prior year. However, we anticipate that advertising prices should revert back to more normal levels as the pandemic further subsides, which should help increase the efficiency and effectiveness of our media spending, and thereby continue to help us gain more new customers in the future. We are also in the process of re-evaluating many of our current marketing relationships, which has resulted in changing some of our marketing partners, with the expectation of improved marketing efficiency and results.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the second fiscal quarter, net income was $6.3 million, or $0.31 diluted per share, compared to $8.4 million, or $0.42 diluted per share for the same quarter last year, a decrease to net income of 25%. For the second fiscal quarter, our gross profit as a percentage of sales was 28.5% compared to 30.5% for the same period a year ago. The percentage decrease for the quarter can be attributed to some of the major manufacturers shifting their funding from discounting product costs to cooperative marketing rebates. There may be an opportunity to improve gross margins in the second half of Fiscal Year 2022, if the shift to prescription medications continues.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We had $106.6 million in cash and cash equivalents, and $19.7 million in inventory with no debt as of September 30, 2021. The Board of Directors also declared a quarterly dividend of $0.30 per share on the Company&#8217;s common stock. The dividend will be payable on November 19, 2021, to shareholders of record at the close of business on November 8, 2021. The Company continues to be committed to returning capital to our stockholders. However, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company&#8217;s financial performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This ends the financial review. Operator, we are now ready to take questions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We will be conducting a question-and-answer session. To ask a question please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You will not be able to ask a question if you are listening to the webcast. You must dial directly into the call to ask a question and also you may press star 2 if you would like to remove your question from the queue as well. One moment, please, while we poll for questions. Our first question is from Anthony Lebiedzinski from Sidoti. Please proceed with your question.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Anthony Lebiedzinski</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes, good afternoon and thank you for taking the questions. Welcome, Matt, and welcome back, Bruce. So, as far as new order sales, obviously, you guys did have&#8212;certainly felt the impact of the advertising market being lower, but kind of what gives you confidence that things will bounce back in the back half of the fiscal year, just curious as to what's driving that. Maybe perhaps, are you seeing some good results or better results so far in the current quarter? I'm just wondering about your confidence level about your ability to bounce back with the new order sales.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Anthony, this is Matt, and thanks for the question. Great to hear from you again. Bruce, feel free to chime in. A couple of things about that. One is, I would say that we're taking small bites too fast approach to looking at our new customer acquisition. We basically have rewired our entire marketing partnerships and agencies in the last, I would say, I've been here two months, so we've done that in the last four weeks, and that would be rolling out very soon. So we're looking at our capital allocation spend to where we spend. I think we've been spending too aggressively in some channels where we haven't seen the return, and we haven't been taking advantage of new sources of traffic where we actually think we have a lot of advantage. That's one.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Two is, we're spending a lot more time rewiring our system and databases around tracking our customers better and really focusing on reengagement. And for rates in general, we are seeing some changes to the rates out there. I think some of the channels, like Facebook, have obviously gotten more expensive due to the loss of first party data to the Apple IDFA decision. So those are some channels that obviously I think are just still getting hotter in terms of increased CPMs and CPCs. But in others we're seeing favorable trends. It depends on the channel, but for us, we're really looking at each channel and seeing how we get incrementality at each channel which is different than what we did in the past.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 4 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Anthony Lebiedzinski</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay, got it. And then in terms of your gross margins, now you did mention that you have been shipping more items like specialty dog food, which obviously is much heavier than the typical pet medication. As we look to align our models here how should we think about this issue, on the one hand it sounds like you're doing a good job with increasing your AOV but how's the gross margin impact going to be because of that?</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Bruce Rosenbloom</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes. Anthony, I'm going to take that question, if you don't mind. As far as our margins for the past quarter, we have as we've maybe spoken offline before, but our vendor shifted funding to our co-op marketing in lieu of discounting products and this negatively impacted our gross margins during the quarter. And it will probably be like that going forward, where instead of getting price discounts off the price of the items or the inventory, these rebates and these promotions are going to be below the line as a&#8212;in the advertising line item. So as far as moving forward with gross margins, that you'll see that as an overriding factor, however, as we've also seen our shift moving back to more prescription, than OTC, we do expect a positive trend in margins moving forward because of that going back to some semblance of normalcy, pandemic versus post-pandemic, when it comes to our mix shift of items.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Anthony Lebiedzinski</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay. Got it. And then, you know, in terms of the capital allocation, was just curious to get your thoughts, Matt, as far as looking at pets for years the Company has been a company with a lot of cash and growing the dividend and started making a very healthy cash position. Just wanted to get your thoughts about that. How should we think about that, especially the dividend what are your thoughts there?</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes, I think there's several things to unpack there. It's a great question. I've been a long listener of Pets earnings calls as well, so I'll try to give a slightly different answer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I'd say with the dividend we're always looking at that and it's always subject to change but we've been pretty consistent with the dividend and nothing to announce here obviously. But, to your cash question, with over $100 million in cash with interest rates being so low, I think there's a lot of opportunities in the space to deploy cash and allocate capital more efficiently to get higher returns. There's also a lot of businesses in the pet ecosystem that fortunately in this market is different than other verticals. There's a lot of ways to partner, a lot of ways to look at M&amp;A as well. So we're certainly going to be looking at those in the future since we do have such a large cash position.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">And lastly, it's a little early for me to articulate the strategy. I've been around for two months. I think the first four weeks felt like six months because there was a lot to do and learn and now I'm kind of settling in and feeling better about things. But yes, I think there's a lot of opportunity to deploy capital differently, especially given the tailwinds in pet ownership. So that's kind of a nonanswer answer, Anthony, other than I think we're taking a fresh look at that and I would expect that we will make some decisions in the coming quarters that we'll obviously update everyone on.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Anthony Lebiedzinski</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Got it. Okay. Well, thanks and best of luck going forward.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Bruce Rosenbloom</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thanks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thanks Anthony.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our next question is Stephanie Wissink from Jefferies. Please proceed with your question.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 5 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stephanie Wissink</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Hi everybody. Thanks for taking our questions. The first is I wanted to just go back to some of the comments in your prepared remarks around vet visits. I think I heard you correctly that there's an inverse correlation, meaning when vet visits go up you tend to see vets sell prescription and OTC directly and so your business feels that impact. Is that the right way to think about it or is there a net second derivative where in follow-up to those primary prescriptions, you'll start to see some of the secondary prescription refills in your business?</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Bruce Rosenbloom</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Hi Steph. This is Bruce. Let me address that question. It really&#8212;the vet visits information was really to try to give an understanding of what we were seeing last year versus this year. Last year during the pandemic, virtually all the vet offices were closed and there really wasn't many alternatives where our pet owners could turn to for medications and many were trying online pet medications for the first time. And so that was definitely something that we welcomed last year. This year, all those clinics were open for business and they're making up for lost time. So, they're making sure that if they haven't seen that pet in a 12-month period they're enforcing and making sure that that pet owner's coming into their clinic. So it's almost a resetting of the prescription cycle and many of the pet owners are going to the vet, buying there, and then we're in line for the refill, and we can sort of &#8211; through our data - we know when it's time for a reorder and we'll go ahead and market for that reorder, or subsequent reorder, and we expect to see that in the second half of this fiscal year, is what I was referring to earlier in the call.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stephanie Wissink</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay, got it. And then my second question is on ad spend. I think you mentioned both that you expect advertising prices to revert. I'm curious if you could just give us a sense of do you expect them to go back to pre-pandemic levels on a purchasing price basis or do you still expect there to be a bit of inflation post-pandemic? And related to that, I think you also used the word less efficient. Could you maybe talk a little bit about what you're doing to tweak your marketing mix or your marketing plans out over the next couple of quarters to try to improve some of the efficiency even if the cost remain a little bit elevated?</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes, and I'll take your second question first. A couple of things. I would say overall the way in which we've been purchasing media is going to change significantly. We're looking at new and I've actually implemented new marketing partners to help us with that that specialize in specific areas of media. I won't get into the channels themselves but obviously Google, Facebook, connected TV, there's a lot of options out there and I think the way we've configured media spend to date needed a fresh pair of eyes, that's one. Two is just adding more data around the decisions that we're making our media buys with another, I'd say, quick win that we've implemented.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">And then lastly, to your first question, media rates have been dancing around quite a bit. I was in the language learning space prior to this with Rosetta Stone and we took advantage of favorable rates during the pandemic because advertisers were leaving things like brand advertising to performance. I would say going into the holiday season it's too early to tell since it's a very competitive time to be buying advertising but I would say that I'm a little bit more optimistic about rates that I was when I started two months ago.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stephanie Wissink</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay, that's great. Thank you for the help.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thank you.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">And again as a reminder if you have any questions, you may press star one on your telephone keypad, doing will ensure yourself a turn in the question and answer queue. Our next question is from Ben Rose with Battle Road. Please proceed with your question.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 6 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Ben Rose</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes. Good afternoon. And I know we haven't had a chance to meet, Matt, but I look forward to meeting you post-call. A couple of questions with regard to pet health advice. On your slides, Matt, you talked about the growth in the telehealth market and I was just curious to know what thoughts you have with regard to the Ask the Vet service that you offer now and whether you envision that being expanded in some way or perhaps being monetized in some way in the future?</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Hey, Ben, and looking forward to catching up in subsequent conversations. Yes, I'm really excited about the pet telehealth space. There has been a lot of innovation in this space. There is a lot of different start-ups that I had talked to personally in the space to get some advice. I think the way I'd start is, I always try to evaluate businesses not only on the TAM and the timing and the kind of the fundamentals but also the customer relationships. An inordinate amount of our customers are wanting additional services from us, they almost&#8212;they are giving us permission to give them more advice than we are today. Because prescriptions are in a way, the milk of the back of the proverbial store with the customer, because they see PetMeds as the expert in pet healthcare. It just so happens as the customer is leaving the store, we're not providing a lot of expert experience yet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">And so, I see pet telehealth as us being very well positioned to add additional services that we don't do today because customers really view us as that specialty pharmacy, they're not viewing us as the mega-retailer with lots of different services. We're not known for selling food, we're not selling&#8212;known for selling dog toys. We're known for providing expert advice. And so for pet telehealth, while the market is really small, I see it as an opportunity to engage with our Autoship customers in really unique ways and then sell them additional services. So nothing to announce, but we're certainly going to be doing a lot of testing even this quarter on this topic, which I hope&#8212;hopefully I'll be able to talk to you about next time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Ben Rose</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay. Great. And with regard to the Company's relationships with the veterinarian community and vet clinics, this is the first time that I heard you quantify the number of veterinarians in clinics that you work with and find that to be an intriguing opportunity. Was curious to know plans that you have to perhaps reduce friction with the veterinarians or to improve relationships with them.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes. Ben, thanks for noticing that. And it was intentional to put that in there because I was quite surprised when I first started at the Company. We have a vet portal that's used today. I've seen other competitors in this space quote numbers, and I think still might be surprised that we have a larger network than most.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I think our relationship with vets has been a little confrontation, to be honest, over the span of the Company when we first started, because we are the pioneers in this space. I think when we&#8212;we would go to the veterinarian conferences; we are probably the least likely to be welcomed. And I think now there is other players in this space and we've kind of opened the door for them. And I think we're kind of seen as a more friendly player in this space, to be honest. Our vet verification rates are as high as they've ever been. I think there's a lot of things we could do in our vet portal to make the veterinarians' life easy. We're very sympathetic to veterinarians. They are overworked. They have some of the highest suicide rates of any profession. And I think that there is a lot we could do to be a better friend of the vet. And our vet portal, I think, has a great start, but I think there's a lot of opportunity to automate what they do in their clinics. And we're going to be pro-vet in terms of how we approach the market, our intent is not to be anti-vet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Ben Rose</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Okay. Thank you very much.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thanks, Ben.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 7 of 8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our questions and answers portion of the call has ended. I would now like to turn the call back to Matt Hulett, the Company's CEO for his concluding remarks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Matt Hulett</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thank you. I want to reiterate what Bruce just covered in his financial highlights section. We are disappointed with our sales results for the quarter. But after my two months on the job, I'm confident there is much we can do and will do to improve our business growth. To be clear, in a market that's growing, PetMeds needs to be&#8212;make the necessary changes to our operating playbook to take advantage of the market trends. In my first weeks here, I've listened in on countless customer service calls, engaged with over 20 pet industry leaders, briefed research analysts and engaged with our own main pharmaceutical partners. I've already seen a lot of core areas that we can, and have already begun to improve, in this business and these include the following. Using more data insights to acquire and retain customers, better segmentation of our customer base in order to drive more mass personalization of our offers and services, improved new customer acquisitions through a different allocation of variable marketing spend and expanded product and services that are already being demanded by our customers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Since I've only been with PetMeds for a short period of time, I'm not ready yet on today's call to provide a comprehensive future strategy or capital allocation plan for the business, and that would be premature. However, I do have a 90-day&#8212;180-day plan that I presented to our Board of Directors and I'll be sharing more about our vision and strategy with you during our Q3 earnings call. But I will say this today, we firmly believe that we can take advantage of the large market tailwinds, leverage the main core strengths we highlighted today and execute on a broader strategic vision for the Company. We look forward to briefing you in the coming quarters on our strategy and our progress. Thank you for listening in. Operator, this ends the conference call.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operator</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Thank you. This ends today's conference call. You may disconnect your lines at this time. Thank you for your participation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="Exhibit 99.1 Page " data-suffix=" of 8" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">Exhibit 99.1 Page 8 of 8</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pets-20211025.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/27/2021 1:51:35 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:pets="http://www.pets.com/20211025" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pets.com/20211025">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20211025_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20211025_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20211025_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.pets.com/20211025/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="pets_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>pets-20211025_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/27/2021 1:51:35 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.pets.com/20211025/role/statement-document-and-entity-information" xlink:href="pets-20211025.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.pets.com/20211025/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>pets-20211025_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/27/2021 1:51:35 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>pets-20211025_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/27/2021 1:51:35 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.pets.com/20211025/role/statement-document-and-entity-information" xlink:href="pets-20211025.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.pets.com/20211025/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>pets20211026b_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20211025.xsd" xlink:type="simple"/>
    <context id="d20218K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20218K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20218K">0001040130</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20218K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20218K">2021-10-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20218K">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20218K">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20218K">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20218K">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20218K">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20218K">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20218K">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20218K">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20218K">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20218K">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20218K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20218K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20218K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20218K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20218K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20218K">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20218K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20218K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140632203492440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Oct. 25,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #%96U,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  Q65M3+\T-Q.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NFGY(Z(N%Z:=0$)B$HA;E'A;1--&B5&[MR<-6R<$#\ Q]B^?
M/TMNM1=Z"/@<!H^!+,:KR75]%-JOV('("X"H#^A4+%.B3\W=$)RB] Q[\$I_
MJ#U"756WX)"44:1@!A9^(3+9&BUT0$5#..&-7O#^,W099C1@APY[BL!+#DS.
M$_UQZEJX &8887#QNX!F(>;JG]C< 79*3M$NJ7$<R[')N;0#A[>GQY>\;F'[
M2*K7F'Y%*^CH<<7.DU^;A_5VPV1=U;S@55'?;?F-J.Y%<_T^N_[PNPB[P=B=
M_<?&9T'9PJ^[D%]02P,$%     @ ,5E;4YE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI**%%B).R7E8K@4!;==3'<M06JF6[ GSVT@15_+0*K4\I?$'M&E/#%R&&![
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MG6%W#U:O\W/C7%L\A>:W*SSW@W$%\/M":WMX<$?1XI>$P;]02P,$%     @
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MX-R#8._AE8P=S8\?=_<#4$L#!!0    ( #%96U,D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  Q65M399!YDAD!  #/ P
M$P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=
M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'
M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-
MF<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*
M1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP
MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,
M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (
M #%96U,'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ ,5E;4R_-#<3O    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ,5E;4YE<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  Q65M3T9Y8QBT$  !5$   &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ,5E;4Y^@&_"Q
M @  X@P   T              ( !<0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  Q65M3EXJ[',     3 @  "P              @ %-#P  7W)E;',O
M+G)E;'-02P$"% ,4    "  Q65M3.JJBYT !   \ @  #P
M@ $V$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ,5E;4R0>FZ*M
M^ $  !H              ( !HQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ ,5E;4V60>9(9 0  SP,  !,              ( !
MB!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  TA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets20211026b_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pets.com/20211025/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="pets20211026b_8k.htm">pets20211026b_8k.htm</File>
    <File>ex_297703.htm</File>
    <File>pets-20211025.xsd</File>
    <File>pets-20211025_def.xml</File>
    <File>pets-20211025_lab.xml</File>
    <File>pets-20211025_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pets20211026b_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "pets-20211025_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pets20211026b_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20211025_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20211025_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pets-20211025.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "pets",
   "nsuri": "http://www.pets.com/20211025",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "pets20211026b_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.pets.com/20211025/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "pets20211026b_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pets.com/20211025/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001437749-21-024344-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-21-024344-xbrl.zip
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MOJM@3)*,HK?9RT0L@%H;;\Z(VKO2/)$;\0DS44)9,VG$3/8Y#1'^!+5$XRC
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M;@R1&V:A0;.MFD'V$;R8?1%L$60G?EJ<(V0ZD1\X4K%F[$%T3<,22%(2_\4
MXC*HUX<!@F$M)D?3KXY2.\GY%2)I=*9_#%O:L'D-S\TL(.+%?,@"SUBV;M@
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M&+; ;A([Q'<YP8!T].N*(_].>&V_W7")N'']3@95W?A8#)0GK3T?2T@UUKG
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M$1'/A;5+]@H'.DO *,1'NN8-JBM_[7-.\AY6*]5?C>%:"<\))^*VN$[X,9A
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MY;<>E]>Z,4,[)YOZBY^_ %!+ P04    "  Q65M3@S%=P=8$  #F+   %0
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M@&0P8U2_M^@@CAA]YUC(@K7'TG1!MQM%T=EOQ#GB-F0$Q[)\I],'.:DY1J2
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M!TY8#VLA\QX/&;>1^S;P0;/O@[AL#YOW-N1A,Q9C%SYPQEN0!\WX$1_8&9N
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MW=;8Y/;V-M:E1VA)JX#8:!+_]3 <IPO(240+)4JJN)2T4^J;0YX2J96\.(3
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M$J'LBG1!67:H/1,\K_](YY<,!6Q>#_SM#OVB#< M? Q+&9*W+X.]'W'0Q*/
M.!\IM_VZMU+C;<6'40VS,V2E0LLO%6K,*"LYVG[(\6I?R4J<WWT2Q^1G62EQ
MXY,25M:9E2Q_^"3+1:?.2I+W'DIBL@:M!/G30T%J;4@K56X]5*7&]+1+T#S)
M5\V.JYT,GB2J]5:OG12>9*L6]K*='IZDJY=<;3LQ/$E/;4UT.U$\R51?Y];;
M2>-)MEJ_36 GA2=9:LT6A9T.GB2GE_=%[.3P*BNUV(6Q<\P\24MK=H#L=/ D
M+[78=3K9<8C/),&&?WX\EJ@?]<]>O/,O4$L#!!0    ( #%96U.M4Y(731
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MA (>8)=B4YEUA5!)9,@<C%-< C$K5Y( @H"EB!VC.LC9HL)8'G]J*26%=9^
MRO:O*9^$A6-6!L,KQ4(1W""7TB8>"Q!X'HC0B*>+U,UXZM<,W&WE>>8%@KMT
MG0CO,'\+;L],?^L/?STQ+4OAC'L,/@!HW9+E$*%;Y</#\L$[T[=F>H].VF8Z
MXVC6/D@"^U7+WC^TC_:W$\%+ 9V\Q@0,S@((R@3Y"V(RZ7(=M2T &>"7)X$D
M V5?G\[EF\%XS*5,<0(MF<2*]#:8T"YT"MT":8U#+Y@RL>!$VK;(95!8[7MA
M)FX"IJ*.Z)9"2-,BN2\F7TOW@D+%^P2M6_CI$+L-*CX$CQNNBW&@^?$5*BIM
MV6JE;)-N$*D1:0;^$&LA#9@G16P--.]N.<5/];4)OUZ)7G#K;]G34^8).B6?
M&75&3]4YC=Q7XAJB/XYK"EM*<*O([VMJ$"O'\R/#N0X@F/7^EX</B$SW]BJ5
MZEK_G"AZ#%?]+!::-YS"V5 H0.8\I!YA$^9$BM_@) G0F,D=D@<N$F3C.R(_
M$B(?'10.?W%(SF]G>PAM#<'H ZRMNE]:8VL[6X+ UP 8?CT*_(?-D*KE?:L"
M?QYJ_9M%7G&^)AVS/00WGD>/\HLTSN^_'99+!\>2*.:Q$+E.?,WV78SPO0AM
MDU#0"Q!;)G[\,+_>D>>5Q8*7@2*-,/2@^\#U5^)JSX ,IL-Q\E'HO!L\TM@!
M@ZT,2+QD ?W'X(MX5,[2]0]VNB]D:2/52G/$G.]Z/8>&H0@@+,%T0C^8D#[S
M@EMD%!8B.\FA]84,]!8;PB7 C6*@12XN$TD^CCQ%?19$TIL2"5HF!U/]I?D@
MZ(.LXIFF63]*Y(.U-A+J3V=E@\"#QO$[S(URG,)+DI>,F=T:'FG[\&T4+TXU
M"N5"W-V=VC.M<&R(3[%%$&T21*LP]W$:CC XV7S+QR[1KW>)!/\X,-\E]XXD
M$8TDW\209D!W"=)66#)!4WZTKN66<6/&DL-M]KS<W\I#DO'](/#Z%#0/6#))
MACC_%ER!LF,^*?)-PD2B)AP=5"K'=\.5NY[6C%+[DL?FY0I-_R$%2ED!,69
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M6WCJ;4<;:M)R,S]'7W+UU@H1/FH.--X]/VOJ7+?4C!M:D_Y\TW)I#]88&.Z
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MNI*KE]?NNH!?#%?P7P2K_S]02P$"% ,4    "  Q65M3P[ZY6OTS   2ZP
M#0              @ $     97A?,CDW-S S+FAT;5!+ 0(4 Q0    ( #%9
M6U.JI%&?<@,  "@.   1              "  2@T  !P971S+3(P,C$Q,#(U
M+GAS9%!+ 0(4 Q0    ( #%96U.#,5W!U@0  .8L   5              "
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7;5!+!08     !@ & (4!   B6      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
